Olmesartan Medoxomil / Amlodipine Besylate / Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 63629-2238

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil / Amlodipine Besylate / Hydrochlorothiazide (NDC 63629-2238). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl636292238)

Label for Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Tablets 20 mg/5 mg/12.5 mg by Bryant Ranch Prepack. The label includes storage instructions, manufacturer information, and states the package contains 30 film-coated tablets for oral use. The product is Rx only and displays the NDC 63629-2238.*

FDA Label Image

Olmesartan Medoxomil (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 1)

Chemical structure of olmesartan medoxomil, depicted as a molecular diagram showing its atoms and bonds.*

FDA Label Image

Amlodipine Besylate (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 2)

Chemical structure diagram showing the molecular formulas of olmesartan medoxomil and amlodipine besylate, two of the active ingredients in this combination drug product.*

FDA Label Image

Hydrochlorothiazide (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 3)

Chemical structure diagram illustrating the molecular configuration of olmesartan medoxomil, one of the active ingredients in the combination tablet of olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide.*

FDA Label Image

Figure 1 (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 4)

Line graph depicting multiple data sets over time with percentages on the vertical axis ranging from 55 to 100. Data series are represented by different symbols including circles, triangles, diamonds, and squares, each corresponding to different treatment groups such as Baseline and various dosages involving HCTZ combinations. The x-axis is unlabeled and indicates sequential measurement points.*

FDA Label Image

Figure 2 (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 5)

A line graph titled 'Mean Ambulatory Systolic Blood Pressure at Endpoint by Treatment and Hour' showing mean systolic blood pressure (mmHg) on the vertical axis and hours post dose (0 to 24) on the horizontal axis. The graph includes multiple treatment groups indicated by different symbols and lines, comparing blood pressure changes over 24 hours post dose in various treatment conditions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.